We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+5.3%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.53B
AUM Growth
+$159M
(+3%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
20.92%
Holding
797
New
64
Increased
251
Reduced
262
Closed
82
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$42M |
| 2 |
CF Industries
CF
|
+$41.4M |
| 3 |
BEAV
B/E Aerospace Inc
BEAV
|
+$36.2M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$33.3M |
| 5 |
Sunoco
SUN
|
+$29.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$55.7M |
| 2 |
ITC
ITC HOLDINGS CORP
ITC
|
+$38.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$38.3M |
| 4 |
Accenture
ACN
|
+$37.2M |
| 5 |
Tesla
TSLA
|
+$35.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Financials | 16.55% |
| 3 | Consumer Discretionary | 12.19% |
| 4 | Industrials | 12.01% |
| 5 | Technology | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
101
Johnson & Johnson
JNJ
$610B
| $8.7M | 0.16% |
86,479
-547,884
| -86% | -$55.7M |
2013 Q2
7 quarters
|
|
|
CLR
102
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $8.69M | 0.16% |
199,032
-506,830
| -72% | -$21.6M |
2013 Q2
7 quarters
|
|
103
Danaher
DHR
$163B
| $8.55M | 0.15% |
149,770
-1,889
| -1% | -$108K |
2013 Q2
7 quarters
|
|
104
ExxonMobil
XOM
$718B
| $8.42M | 0.15% |
99,030
-4,182
| -4% | -$371K |
2013 Q2
7 quarters
|
|
105
iShares Russell 2000 ETF
IWM
$77.5B
| $8.15M | 0.15% |
65,500
+4,823
| +8% | +$581K |
2013 Q2
7 quarters
|
|
106
Procter & Gamble
PG
$365B
| $7.87M | 0.14% |
96,073
-251
| -0.3% | -$21.6K |
2013 Q2
7 quarters
|
|
107
Booking.com
BKNG
$125B
| $7.33M | 0.13% |
157,375
-8,700
| -5% | -$389K |
2013 Q3
6 quarters
|
|
108
GE Aerospace
GE
$324B
| $7.16M | 0.13% |
60,205
-192
| -0.3% | -$22.9K |
2013 Q2
7 quarters
|
|
109
Caesarstone
CSTE
$93.4M
| $6.98M | 0.13% |
114,970
-2,817
| -2% | -$174K |
2013 Q2
7 quarters
|
|
110
SLB Ltd
SLB
$71.8B
| $6.94M | 0.13% |
83,144
-236,235
| -74% | -$19.7M |
2013 Q2
7 quarters
|
|
111
Pfizer
PFE
$168B
| $6.64M | 0.12% |
201,141
-2,289
| -1% | -$72.8K |
2013 Q2
7 quarters
|
|
|
MJN
112
DELISTED
Mead Johnson Nutrition Company
MJN
| $6.56M | 0.12% |
65,282
-3,379
| -5% | -$341K |
2013 Q2
7 quarters
|
|
113
DELISTED
Dominion Energy Midstream Ptr LP
DM
| $6.55M | 0.12% |
157,870
+4,240
| +3% | +$160K |
2014 Q4
1 quarter
|
|
114
Baidu
BIDU
$28.1B
| $6.48M | 0.12% |
31,076
-161,649
| -84% | -$34.6M |
2013 Q2
7 quarters
|
|
115
Intel
INTC
$504B
| $6.42M | 0.12% |
205,408
+1,035
| +0.5% | +$34.9K |
2013 Q2
7 quarters
|
|
|
FRC
116
DELISTED
First Republic Bank
FRC
| $6.09M | 0.11% |
106,719
-1,154
| -1% | -$62.8K |
2013 Q2
7 quarters
|
|
|
KIQ
117
DELISTED
Kelso Technologies Inc.
KIQ
| $6.09M | 0.11% |
1,334,729
+68,200
| +5% | +$313K |
2014 Q4
1 quarter
|
|
118
Grifois
GRFS
$5.13B
| $6.03M | 0.11% |
367,650
-21,120
| -5% | -$354K |
2013 Q2
7 quarters
|
|
119
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $6M | 0.11% |
146,840
+11,760
| +9% | +$478K |
2013 Q2
7 quarters
|
|
120
McKesson
MCK
$116B
| $6M | 0.11% |
26,514
-15
| -0.1% | -$3.33K |
2013 Q4
5 quarters
|
|
121
CME Group
CME
$104B
| $5.91M | 0.11% |
62,393
+2,378
| +4% | +$220K |
2013 Q2
7 quarters
|
|
122
DELISTED
Luxottica Group
LUX
| $5.86M | 0.11% |
93,488
+3,748
| +4% | +$224K |
2013 Q2
7 quarters
|
|
123
Euronet Worldwide
EEFT
$2.45B
| $5.86M | 0.11% |
99,683
-3,403
| -3% | -$180K |
2013 Q3
6 quarters
|
|
124
DELISTED
Hanesbrands
HBI
| $5.82M | 0.11% |
173,531
-4,205
| -2% | -$127K |
2014 Q4
1 quarter
|
|
125
lululemon athletica
LULU
$11.5B
| $5.65M | 0.1% |
88,286
+4,524
| +5% | +$290K |
2013 Q3
6 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Geneva Advisors held 797 positions worth $5.53B, up 3% from $5.37B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Advisors's Q1 2015 filing shows 64 new, 251 increased, 262 reduced and 82 closed positions. Its largest new stake was Ulta Beauty: 303,437 shares worth $45.8M. The largest sale was Johnson & Johnson, an estimated $55.7M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geneva Advisors's largest Q1 2015 buy was Ulta Beauty: 303,437 shares worth $45.8M.
- Geneva Advisors added most to CF Industries in Q1 2015, an estimated $41.4M increase.
- Geneva Advisors's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $55.7M.
- Geneva Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $38.3M.
- Geneva Advisors's ten largest holdings make up 21% of its $5.53B portfolio in Q1 2015.
- Geneva Advisors opened 64 new positions and closed 82 in Q1 2015.
- Geneva Advisors's portfolio value rose 3% quarter-over-quarter to $5.53B.
Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.